| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
mucin 16, cell surface associated | 0.479 | 0.808 | 8.3E-112 |
|
disease | 0.100 | None | 0.938 | 2 | 0 | 2004 | 2020 | ||||||||
|
DNA methyltransferase 3 alpha | 0.445 | 0.846 | 7.4E-39 |
|
disease | 0.020 | None | 1.000 | 1 | 0 | 2007 | 2012 | ||||||||
|
angiotensin I converting enzyme | 0.328 | 0.923 | 1.0E-37 |
|
disease | 0.030 | None | 1.000 | 2 | 0 | 2005 | 2014 | ||||||||
|
macrophage stimulating 1 receptor | 0.542 | 0.808 | 7.9E-37 |
|
disease | 0.020 | None | 1.000 | 1 | 0 | 2005 | 2017 | ||||||||
|
BRCA1 DNA repair associated | 0.367 | 0.923 | 9.2E-29 |
|
disease | 0.040 | None | 1.000 | 1 | 0 | 2003 | 2015 | ||||||||
|
BRCA2 DNA repair associated | 0.379 | 0.846 | 2.4E-25 |
|
disease | 0.040 | None | 1.000 | 1 | 0 | 2003 | 2019 | ||||||||
|
complement C9 | 0.619 | 0.692 | 1.6E-24 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
complement C5 | 0.550 | 0.731 | 8.1E-24 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
lactotransferrin | 0.543 | 0.846 | 1.3E-21 |
|
disease | 0.310 | None | 1.000 | 1 | 0 | 2007 | 2011 | ||||||||
|
protein tyrosine phosphatase non-receptor type 22 | 0.438 | 0.846 | 3.5E-21 |
|
disease | 0.050 | None | 1.000 | 1 | 0 | 2008 | 2016 | ||||||||
|
macrophage stimulating 1 | 0.465 | 0.885 | 4.8E-19 |
|
disease | 0.020 | None | 1.000 | 1 | 0 | 2005 | 2018 | ||||||||
|
matrix metallopeptidase 1 | 0.385 | 0.885 | 7.7E-18 |
|
disease | 0.070 | None | 1.000 | 2 | 0 | 1997 | 2010 | ||||||||
|
cytochrome P450 family 1 subfamily A member 1 | 0.436 | 0.846 | 1.1E-17 |
|
disease | 0.100 | None | 1.000 | 1 | 0 | 2000 | 2016 | ||||||||
|
matrix metallopeptidase 9 | 0.305 | 0.923 | 1.9E-17 |
|
disease | 0.300 | None | 0.931 | 6 | 0 | 2002 | 2019 | ||||||||
|
matrix metallopeptidase 3 | 0.408 | 0.885 | 5.7E-15 |
|
disease | 0.060 | None | 1.000 | 3 | 0 | 2002 | 2011 | ||||||||
|
interleukin 1 receptor type 2 | 0.593 | 0.846 | 6.5E-15 |
|
disease | 0.080 | None | 1.000 | 6 | 0 | 2002 | 2012 | ||||||||
|
heparanase | 0.425 | 0.808 | 2.3E-14 |
|
disease | 0.040 | None | 0.750 | 2 | 0 | 2004 | 2008 | ||||||||
|
killer cell immunoglobulin like receptor, three Ig domains and long cytoplasmic tail 1 | 0.475 | 0.769 | 8.4E-14 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
anti-Mullerian hormone | 0.476 | 0.846 | 3.4E-12 |
|
disease | 0.070 | None | 1.000 | 1 | 0 | 2008 | 2019 | ||||||||
|
major histocompatibility complex, class I, G | 0.461 | 0.769 | 1.4E-11 |
|
disease | 0.040 | None | 1.000 | 2 | 0 | 2006 | 2018 | ||||||||
|
GC vitamin D binding protein | 0.489 | 0.885 | 2.7E-11 |
|
disease | 0.030 | None | 1.000 | 1 | 0 | 2005 | 2019 | ||||||||
|
steroidogenic acute regulatory protein | 0.513 | 0.808 | 8.8E-11 |
|
disease | 0.030 | None | 1.000 | 1 | 0 | 2008 | 2009 | ||||||||
|
paraoxonase 1 | 0.409 | 0.885 | 9.8E-11 |
|
disease | 0.020 | None | 1.000 | 1 | 0 | 2008 | 2019 | ||||||||
|
interleukin 16 | 0.501 | 0.846 | 1.2E-10 |
|
disease | 0.040 | None | 1.000 | 1 | 0 | 2005 | 2018 | ||||||||
|
catalase | 0.359 | 0.962 | 1.6E-10 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 2002 | 2002 |